Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by LIU, J.
Right arrow Articles by KLAASSEN, C. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LIU, J.
Right arrow Articles by KLAASSEN, C. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press

research-article

Absorption and Distribution of Cadmium in Metallothionein-I Transgenic Mice

JIE LIU and CURTIS D. KLAASSEN1

Department of Pharmacology, Toxicology, and Therapeutics, Center for Environmental Health and Occupational Medicine, University of Kansas Medical Center Kansas City, Kansas 66160

Received June 12, 1995; accepted September 8, 1995

Metallothionein-I transgenic (MT-TG) mice have higher concentrations of MT in the stomach (10x), small intestine (4x), large intestine (6x), liver (15x), and kidney (5x) than control mice. The purpose of the present study was to use MT-TG mice to determine whether increased concentrations of MT affect cadmium (Cd) absorption and distribution. A single dose of 109Cd was given to control and MT-TG mice orally (0.3–300 µmol/kg, 200 µCi/kg) or intravenously (0.03–10 µmol/kg, 20 µCi/kg). Cd concentrations in 15 tissues were quantified 7 days later. Higher MT concentrations in tissues of MT-TG mice had no appreciable effects on the concentration of Cd in tissues compared to controls. An exception to this was the MT-TG mice given the highest dose of Cd (300 µmol Cd/kg, po), which had twice the tissue Cd concentration of controls. Approximately 60% of the Cd administered iv was retained in the tissues; retention of Cd in MT-TG mice was similar to that in controls. In both control and MT-TG mice only 0.1–0.3% of Cd administered po was retained, except for 1–3% at the higher doses (100 and 300 µmol/kg). Cd administered iv distributed mainly to the liver (70%) and kidney (10%) and was independent of dose. In contrast, when administered po, distribution of Cd to the liver increased from 40 to 75% of the dose, whereas distribution to kidney decreased from 30 to 7% as doses were increased from 0.3 to 300 µmol/kg. No difference in pattern of Cd distribution to various organs was observed between control and MT-TG mice. These data indicate that higher concentrations of MT in MT-TG mice do not appear to inhibit the gastrointestinal absorption of Cd nor alter the organ distribution of Cd.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.